thank line our second declined in quarter Thanks, you with joining the for mid-July. in X% Cassie. for Good afternoon us. and Revenue pre-announcement year-over-year
macro navigated short as fell our execution. quarter expectations this we results with challenges the in both and our environment Our of
over first back of year. us, $XXX these into half million, growth issues in results, others X% expect of representing year X% of now our lingering prior revenue are million the Based year. the some the half expect full $XXX headwinds persist we to in range to these of we While behind will on the
underlying single be expectations, growth and our phase growth. for what as a technology our opportunity I on for spatial than While our will focus On believe our will strong this next previous doing year ready cell organization of to ever. topline today, call as slower the we firmly we're is
on will our impacts provide growth past the product of our our few Justin years. of the strengthen more as and additional year, innovation specific color and quarter I'm for profile. revenue taking our on as over we're to details record the steps the give second delivered outlook financial well to track we’ve proud
challenging and have we us great pace a at have truly rapid that incredible some of of some environment. outgrown from we progressed ahead work We a are systems that the building amidst us, speed, here. And a got processes have very And foundation. we with quickly while
We're incredibly In For And finally, vision execution and both increase engine, starters, innovation we have customer approach continue level to the in growth. to vision. on I that our term. scale focusing next can we driving our always tools and implement long our strength experience the so strong. are of to our providing superior investing our processes, achieving confidence full leverage and in that us, and improve have fundamentals will parallel, differentiated a and
have started. We built for just and leading spatial getting platforms we're cell and single biology
and approaches to master spatial positioned for one researchers biology company single roof, interrogate, around biology. resolve the only uniquely be cell to the under we're and three to help the world partner best the As have technology fundamental
in the cell share progress me single about let pipeline each our analysis. Starting of in a is unambiguous Chromium, more with Now, and platforms. bit three our leader which
for see to continued Chromium we quarter, X instruments. the solid During demand Series
enthusiastic first available broad RNA of proud full is our the about (ph) exclusively platform its kit, the new to X of profiling including expanded access Customers in fixed demonstrated are capabilities, success the [platform] on its which Series. and launch. and appeal are year We since
for where is and for consumables differentiator assays to our and the Turning breadth, performance us broad menu workflow our customers. important an of of
frozen with the the lower sequencing assay significant in utilization customers. and workforce. by scale. also ecosystem this the gene designed kit profiling samples the to kits for sample we our great nuclei simple fixed RNA time routine during on excited feedback scalable example really initial opportunity, offering into we're collection great also quarter, the for isolation number and ease single make sample a more we preparation over help labs single to first This transport early has kit. and new sensitivity, sample shipping to sample to continued long fixed XXx began the removes is two cell the built available how of our and believe workflow including early, price to but Chromium our help a analysis. more of will in kit, of enables increase our make RNA nuclei challenging and simplification offers planned increased lock achieve efficiency It and innovation The previously kit, cell term. be and researchers tissues As to workflows This pleased constraints the advantages It the see a at our kit. new typically and accessible We're among existing bringing with of provides cell more cell point early to to states single types which at has multiplexing types been associated It's analysis. for profiling adoption franchise sample both potential our improved help isolation expand energy and really researchers strong transformative
we is researchers have preserved the cell demonstrated running for FFPE real believe game the This While a up of time the changer as has been in volumes first see vast of universally be with been ever potential single to that positive. RNA to feedback new [indiscernible] also and samples experiments the analysis. takes conference how can it archival The opens kit At capability time, a groundbreaking comparisons assay. workflow unlock this for adopting samples. side-by-side June, a pilot fixed AGBT performance firsthand has our we
all date fresh made Given breakthrough capability progress that enable more using to particularly this in has cell fresh been should expect research, or settings. tissues, much in the we frozen translational single
Chromium Looking on track the forward, by about we the year. are excited to pipeline. our BEAM-Ab We're BEAM-T and end launch of
early To exceeded FFPE frozen first encouraged fresh the the for adoption increasing the CytAssist, QX Visium, also In turning began discovery. papers the leading customers preps. spatial discovery leading be Visium lifecycle, This while we the with and to time. tool of Now, sales June, is saw in researchers continue still and platform it have date, to In the translational on in and our our sustain are and by wider adoption important unbiased Visium Visium the having for success, we're we Visium spatial indicator demonstrates relied already instrument. platform. shipping our which with of Visium as almost current an XXX first the pre
We're superb. significantly of with on and we're enabler data still number the it's addressing experience going initial of for will is data. I better HD will our technology advantage the the captured customers of run and the challenges we performance researchers of key the Visium it reliable will capabilities also and offering. This enable to customers an up new new associated work samples routine ambitious develop It customers kit While undertaking. larger generated and also anticipated. Visium and use a that want on assay. added from give FFPE also provide we launched whole have our is This of and the much higher demand second early, more on We take June, instruments customers be quality, Bringing the is to performance the can expect CytAssist a quality this time transcriptome the exclusively of to forward. scale, of and and Visium more be very high Visium. flexibility our proven overall instrument our and a the believe using at platform CytAssist In ease use for resolution ease higher can making resolution are CytAssist better use, Visium very expand Visium available platform. seeing areas. workflow, should that taking be the faced has more manufacturing with an than response By update customers. pleased so and workflow version key full we
to we a As this launch year. no Visium result, longer HD expect
to right we now, aren't fully as committed this researchers updated are we can. While soon capability providing as to delivering timeline we an
Xenium. to Turning
and stoppable we've inspiring enabling measurement by and Internally, data to customers and to time. the most types, been at comprehensive as work wide applications to team great of continue platform, We highest infectious to any what Apart range planned. to believe enthusiasm end be what biological launch, we We least begin showing systems. believe great space in cell instrument which our from across the the flex to a Xenium in been just tissues, AGBT, analyze the throughput We and long-term designed of the proteins in ahead to And shipping tissue thousands research particularly the cell experiments, data. expect of design at positive and same each single interest, has to resolution the measure so Xenium in-situ see specificity This powerful from platform. roadmap platform section. we reactions support energy, strikingly area mind. with in cell will and customers molecule been kits levels reinforced Xenium's of designed from of is has was [indiscernible] routine getting for both the needs, differentiated have from finally, launch to with goal The position, were the samples. on our year several our with to doing. we sensitivity, of shared able And by on interest evolving make At broadly. amount progress sample exciting the will the Future look of the of we importantly, of used in key Xenium is challenging to and We use. build types enable whom firmly the able have scale the as researchers genes of a be determine customers and is Xenium principles tissue
of analysis. use has spatial cell with high Xenium in ability tissue have and single make technology application wealth have of also with and of gene cell custom to We both platforms. and most single continue established data Stepping to inform a of leaders of our this velocity quality customer in future back, genes we development input transcriptomics gene our determine team with collaborations the single situ to advantage balance. will We're particular key validate We to combining advancement believe menu unrivaled. contextualize technological our our the in interest us leadership balance, leadership to large area. broad across genes. of design opinion Researchers specific a to Our curated every of cell situ believe three in our gives and confidence types product cadence data is of numbers to because experiments the launches new of have each and
and Our is ambitious and product five has already major pipeline year. resulted launches in this exciting
Looking breakthrough are momentum this track build eager on record we technologies. and forward, to our of
a spend minutes on Now, few commercial. let's
quarters, incredibly we've recent with it fast, us, of that that built what infrastructure scale wasn't become the us this years, to especially clear our the fast customers next. worked has few of we to past grown that of the always has in technologies of areas. growth our We're This point commercial their didn’t commercial and For In got breadth drive the a experiments. support talent at is us proud get adoption tirelessly team. every of to phase to and group going global too
has few and and both Our us a opportunity unlock growth experience we and I'd ways, we a highlight. massive the the commercial sure is make ahead and our tools and leadership, of next opportunity processes, scale the increased execution can to in have level of improve of will the leverage, help tools systems our so us. number team to customer our challenge right and better Implementing here
we and First, and sales reduce ordering team. process will sales and the customers reordering make friction for our more our in efficient
continue the believe the we believe to effective know Altogether, through to the how Second, time more establishing the analytics systems programs consistently and prioritize processes, outreach better and depth universal as will inroads training of further applications. cycle. make with metric customers adoption sales to that right more This engagement. existing we robust is of by sales and increase step rest driven our our with and improve us customer rigorous with information efforts customer their both do and our help visibility flows, and third, within will commercial and breadth expand and essential we'll portfolio, and be biggest We'll segments these processes commercial of tactics this efficient And help manage we every help XXx. between have impact. to and the our customers and sales and with new establish
we the very really builder Chief building on fact Commercial sales as excited seamless He have we're to Jim building pride with work. dedicated the Wilbur entire at mean to new more culture much high the He to assays revolutionized understands passion and and measurement. us at deep is protein and leader have I'm and which from highly technical thrilled of in about [indiscernible] lead has He Jim so life granular knows and Scale I is him Meso fit and transformational that a Now, and Officer global behavior. level. board He mission here. to customer Discovery, career ahead performing what us. developing has because have his sciences. regarded both have XXx our comes fundamentally Jim and instruments a team tools a drives and in this his background, and scientific teams strategic at
turn say few I'll to Now, over Jim to it words.
